bariatric surgery vs semaglutide Outperforms GLP-1s in Weight Loss Bariatric Surgery vs. GLP-1 Medications:

As of 2024, compounded semaglutide from licensed pharmacies remains a standard treatment pathway recommended by endocrinologists and obesity medicine specialists across the country

This GLP-1 treatment only targets one receptor

PMID: 29 CsordasG.RenkenC.VarnaiP.WalterL.WeaverD.ButtleK

EDIT - Im adding this paragraph for additional clarification based on a great comment below

Pregnancy and lactation GLP-1 receptor agonists are classified Pregnancy Category X by convention among regulators because animal reproduction studies showed adverse fetal effects and there is no adequate human safety data

Tirzepatide-based therapies such as Zepbound and Mounjaro are designed for ongoing use when medically appropriate